H2G Green Limited (SGX:5AI)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions SGD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 7, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	18	10	14	26	17	26
Market Cap Growth	-28.16%	-28.16%	-45.00%	55.76%	-35.13%	108.00%
Enterprise Value	23	17	12	32	17	17
Last Close Price	0.01	0.01	0.01	0.02	0.02	0.04
PS Ratio	1.14	0.66	1.40	1.89	2.30	5.37
PB Ratio	0.73	0.42	0.66	1.34	1.52	1.87
P/TBV Ratio	1.04	0.60	0.99	1.75	1.65	1.97
EV/Sales Ratio	1.48	1.07	1.17	2.34	2.36	3.66
EV/FCF Ratio	-2.93	-	-	-	-	-
Debt / Equity Ratio	0.37	0.37	0.30	0.42	0.57	0.36
Asset Turnover	0.44	0.44	0.31	0.49	0.32	0.23
Inventory Turnover	2.58	2.58	1.67	1.91	1.33	1.16
Quick Ratio	1.93	1.93	1.66	1.55	0.97	2.04
Current Ratio	2.68	2.68	2.31	2.28	1.68	2.70
Return on Equity (ROE)	-32.78%	-32.78%	-43.90%	-30.53%	-22.55%	-23.60%
Return on Assets (ROA)	-11.80%	-11.80%	-14.02%	-7.93%	-7.27%	-10.42%
Return on Capital (ROIC)	-13.76%	-13.76%	-16.82%	-9.92%	-9.17%	-12.04%
Earnings Yield	-21.76%	-37.71%	-42.07%	-12.87%	-16.71%	-12.45%
FCF Yield	-44.32%	-76.81%	-72.44%	-17.94%	-9.09%	-8.59%
Buyback Yield / Dilution	-8.69%	-8.69%	-27.71%	-46.35%	-19.42%	-3.57%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.